OncoMatch/Clinical Trials/NCT03659448
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Is NCT03659448 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies SGM-101 for colorectal neoplasms.
Treatment: SGM-101 — The performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Colorectal Cancer
Disease stage
Required: Stage PERITONEAL METASTASIZED (clinical TNM)
primary cT4 colon cancer or primary cT3/4 rectal cancer, recurrent colorectal cancer or peritoneal metastasized colorectal cancer
Lab requirements
Blood counts
Absolute neutrophils counts below 1.5 x 10^9/L, Platelet count below 100 x 10^9/L, Hemoglobin below 4 mmol/L (females) or below 5 mmol/L (males) excluded
Kidney function
Serum creatinine above 1.5 times the ULN excluded
Liver function
Aspartate AminoTransferase, Alanine AminoTransferase, Gamma Glutamyl Transferase or Alkaline Phosphatase levels above 5 times the ULN excluded; Total bilirubin above 2 times the ULN excluded
Laboratory abnormalities defined as: Aspartate AminoTransferase, Alanine AminoTransferase, Gamma Glutamyl Transferase or Alkaline Phosphatase levels above 5 times the ULN or; Total bilirubin above 2 times the ULN or; Serum creatinine above 1.5 times the ULN or; Absolute neutrophils counts below 1.5 x 10^9/L or; Platelet count below 100 x 10^9/L or; Hemoglobin below 4 mmol/L (females) or below 5 mmol/l (males);
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- City of Hope National Medical Center · Duarte, California
- Moores Cancer Center - UCSD Health · La Jolla, California
- Cleveland Clinic Florida · Weston, Florida
- Massachusetts General Hospital · Boston, Massachusetts
- University of Massachusetts · Worcester, Massachusetts
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT03659448 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage PERITONEAL METASTASIZED is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages